Asana Reports Positive Preclinical Data of Treatment for Ulcerative Colitis

Asana Reports Positive Preclinical Data of Treatment for Ulcerative Colitis
Asana Medical has announced positive data from a preclinical study using an innovative liquid treatment called Extracellular Matrix Hydrogel (ECMH) for the treatment of ulcerative colitis (UC) and other gastrointestinal diseases. The study, sponsored by Asana, was conducted in partnership with a team led by Dr. Stephen Badylak, MD, PhD, at the University of Pittsburgh’s McGowan

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

6 comments

  1. Peter Trahern says:

    This is great news for sufferers of UC, myself being one of them. I hope and pray you are able to carry out successful human clinical tests in 2017 and I pray this is allowed to be given to persons affected to help with this horrible disease. I would like to be informed if possible please of future developments.

    • Tim Bossie says:

      You are exactly right, this is a horrible illness and we hope that researchers are able to make major breakthroughs in the next year! Thank you for the comment and hope you are doing well.

  2. Kathy Dixey says:

    My daughter suffers from Ulcerative colitis and I would love to be kept updated with news of any research which may eventually lead to a cure for this insidious condition

    • Tim Bossie says:

      We are very sorry to hear about your daughter. We do hope she is doing good now. Have you signed up for your newsletter in order to get the latest articles as they are posted? Or, you can also Like our Facebook page to keep updated.

Leave a Comment

Your email address will not be published. Required fields are marked *